Oxford BioMedica PLC (OXB) — Tangible Net Worth Ratio
Oxford BioMedica PLC (OXB) has a Tangible Net Worth Ratio of 25.7% as of June 2025. This metric is calculated by deducting intangible assets (GBX24.32 Million) from net assets (GBX32.73 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See OXB net asset value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Oxford BioMedica PLC Tangible Net Worth Ratio (1996–2024)
This chart shows how Oxford BioMedica PLC's Tangible Net Worth Ratio has changed across 30 annual periods from 1996 to 2024. As of June 2025, the ratio stands at 25.7%, reflecting net assets of GBX32.73 Million with intangible assets of GBX24.32 Million GBX. Also explore OXB year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Oxford BioMedica PLC (1996–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Oxford BioMedica PLC from 1996 to 2024, covering 30 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Oxford BioMedica PLC market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 51.7% | GBX60.49 Million | GBX29.22 Million | GBX231.64 Million | ▼ -8.5 pp |
| 2023 | 60.2% | GBX77.83 Million | GBX30.98 Million | GBX252.34 Million | ▲ +4.7 pp |
| 2022 | 55.4% | GBX236.19 Million | GBX105.22 Million | GBX460.18 Million | ▼ -44.5 pp |
| 2021 | 100.0% | GBX187.34 Million | GBX52.00K | GBX237.23 Million | ▲ +0.0 pp |
| 2020 | 99.9% | GBX112.75 Million | GBX73.00K | GBX183.93 Million | ▲ +0.1 pp |
| 2019 | 99.9% | GBX75.63 Million | GBX95.00K | GBX122.93 Million | ▲ +0.2 pp |
| 2018 | 99.7% | GBX34.74 Million | GBX117.00K | GBX112.40 Million | ▲ +1.2 pp |
| 2017 | 98.4% | GBX6.15 Million | GBX97.00K | GBX65.40 Million | ▲ +9.0 pp |
| 2016 | 89.5% | GBX12.62 Million | GBX1.33 Million | GBX56.94 Million | ▲ +5.5 pp |
| 2015 | 84.0% | GBX10.89 Million | GBX1.74 Million | GBX51.85 Million | ▼ -6.9 pp |
| 2014 | 90.9% | GBX23.04 Million | GBX2.11 Million | GBX33.80 Million | ▲ +20.4 pp |
| 2013 | 70.4% | GBX8.90 Million | GBX2.63 Million | GBX13.64 Million | ▼ -14.7 pp |
| 2012 | 85.1% | GBX19.64 Million | GBX2.93 Million | GBX24.42 Million | ▲ +2.6 pp |
| 2011 | 82.5% | GBX17.77 Million | GBX3.11 Million | GBX26.09 Million | ▲ +40.1 pp |
| 2010 | 42.4% | GBX11.61 Million | GBX6.68 Million | GBX25.64 Million | ▼ -4.6 pp |
| 2009 | 47.0% | GBX20.98 Million | GBX11.12 Million | GBX43.95 Million | ▼ -5.2 pp |
| 2008 | 52.2% | GBX23.27 Million | GBX11.12 Million | GBX43.12 Million | ▼ -1.1 pp |
| 2007 | 53.3% | GBX31.93 Million | GBX14.91 Million | GBX61.16 Million | ▼ -41.2 pp |
| 2006 | 94.5% | GBX30.09 Million | GBX1.67 Million | GBX35.54 Million | ▼ -2.0 pp |
| 2005 | 96.5% | GBX46.60 Million | GBX1.64 Million | GBX49.24 Million | ▲ +2.6 pp |
| 2004 | 93.8% | GBX26.38 Million | GBX1.63 Million | GBX28.58 Million | ▼ -5.8 pp |
| 2003 | 99.6% | GBX35.21 Million | GBX135.00K | GBX36.71 Million | ▲ +0.3 pp |
| 2002 | 99.3% | GBX25.53 Million | GBX185.00K | GBX26.79 Million | ▼ -0.1 pp |
| 2001 | 99.4% | GBX37.51 Million | GBX234.00K | GBX39.26 Million | ▲ +1.6 pp |
| 2000 | 97.8% | GBX12.98 Million | GBX283.00K | GBX14.32 Million | ▲ +6.6 pp |
| 1999 | 91.3% | GBX3.80 Million | GBX332.00K | GBX4.60 Million | ▼ -0.7 pp |
| 1998 | 92.0% | GBX4.76 Million | GBX381.00K | GBX5.24 Million | ▲ +7.6 pp |
| 1997 | 84.4% | GBX2.76 Million | GBX431.00K | GBX3.20 Million | ▲ +28.1 pp |
| 1996 | 56.3% | GBX1.12 Million | GBX492.00K | GBX1.25 Million | ▲ +0.0 pp |
| 1996 | 56.3% | GBX1.12 Million | GBX492.00K | GBX1.25 Million | — |